What is going on is no credible information from Missling.
I for one have ,on occasion, questioned Dr.M. silence/riding low on the horizon Comm. style. BUT, with all the trigger happy fools on Biotech WS and considering the history of biotech false positives it is just as well that we just let it flow right now. Rather than spending a lot of time resetting wrong data interpretation we are better off presenting a stable-planful-execution-controlled image. Although it is hard to swallow a lot of second guessing and serious questions it is (IMO) the best management policy at this point.
We will know it when we see it. Actually, the next strategic moves will likely be made by our selective suitors, IMO. For example, BIIB is done-tote, unless they can acquire some licenses from us ASAP. And, I am sure they know that.
News 
Market Data 
Discover 
